Your shopping cart is currently empty

β-Endorphin (1-27) (human) acetate, existing in the hypophysis cerebri and hypothalamus, exhibits antinociception activity. β-Endorphin (1-27) (human) acetate is an agonist of opioid receptor, showing preferred affinity for μ-opioid receptor and δ-opioid

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $82 | In Stock | In Stock | |
| 5 mg | $183 | In Stock | In Stock | |
| 10 mg | $272 | In Stock | In Stock | |
| 25 mg | $413 | In Stock | In Stock | |
| 50 mg | $580 | In Stock | In Stock | |
| 100 mg | $777 | - | In Stock | |
| 200 mg | $1,030 | - | In Stock |
| Description | β-Endorphin (1-27) (human) acetate, existing in the hypophysis cerebri and hypothalamus, exhibits antinociception activity. β-Endorphin (1-27) (human) acetate is an agonist of opioid receptor, showing preferred affinity for μ-opioid receptor and δ-opioid |
| In vitro | β-Endorphin (1-27) (human) acetate inhibits the conduction of pain and agitation of nociceptors to exert an analgesic effect. β-Endorphin (1-27) (human) acetate combines together with the opioid receptors in hyperalgesia. β-Endorphin (1-27) (human) acetate suppresses the release of substance P at the level of spinal cord and blocks the conduction of pain on the primary sensory neurons. β-Endorphin (1-27) (human) acetate activates the endogenous analgesia system located in the CNS[1]. |
| Synonyms | β-Endorphin (1-27) (human) acetate(76622-84-9 Free base) |
| Molecular Weight | 3082.52 |
| Formula | C141H221N33O42S |
| Smiles | CCC(C(NC(C(NC(C(NC(C(NC(C(NC(C(NC(C(NC(C(NC(C(NC(C1CCCN1C(C(NC(C(NC(C(NC(C(NC(C(NC(C(NC(C(NC(C(NC(C(NC(CNC(CNC(C(N)CC2=CC=C(O)C=C2)=O)=O)=O)CC3=CC=CC=C3)=O)CCSC)=O)C(O)C)=O)CO)=O)CCC(O)=O)=O)CCCCN)=O)CO)=O)CCC(N)=O)=O)C(O)C)=O)=O)CC(C)C)=O)C(C)C)=O)C(O)C)=O)CC(C)C)=O)CC4=CC=CC=C4)=O)CCCCN)=O)CC(N)=O)=O)C)=O)C(NC(C(NC(C(NC(C(NC(C(NC(C(O)=O)CC5=CC=C(O)C=C5)=O)C)=O)CC(N)=O)=O)CCCCN)=O)C(CC)C)=O)C.CC(O)=O |
| Sequence | DL-Tyr-Gly-Gly-DL-Phe-DL-Met-DL-xiThr-DL-Ser-DL-Glu-DL-Lys-DL-Ser-DL-Gln-DL-xiThr-DL-Pro-DL-Leu-DL-Val-DL-xiThr-DL-Leu-DL-Phe-DL-Lys-DL-Asn-DL-Ala-DL-xiIle-DL-xiIle-DL-Lys-DL-Asn-DL-Ala-DL-Tyr |
| Sequence Short | YGGFMXSEKSQXPLVXLFKNAXXKNAY |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.